Results 41 to 50 of about 7,165,349 (311)
Lower incidence of chronic graft-versus-host disease after ruxolitinib plus extracorporeal photopheresis versus ruxolitinib alone in steroid-refractory acute graft-versus-host disease following allogeneic stem cell transplantation
Haematologica
We compared long-term outcomes in 78 patients with steroid-refractory acute graft-versushost disease (SR-aGVHD) treated at the University Medical Center Hamburg, Germany between December 2015 and August 2022 who received either ruxolitinib alone (Ruxo ...Iryna Lastovytska, Silke Heidenreich, Evgeny Klyuchnikov, Christian Niederwieser, Nico Gagelmann, Johanna Richter, Radwan Massoud, Kristin Rathje, Tetiana Perekhrestenko, Gaby Zeck, Catherina Lück, Dietlinde Janson, Christine Wolschke, Francis Ayuk, Nicolaus Kröger +14 moredoaj +1 more sourceStudy protocol: Phase I/II trial of induced HLA-G+ regulatory T cells in patients undergoing allogeneic hematopoietic cell transplantation from an HLA-matched sibling donor
Frontiers in Medicine, 2023 Regulatory T-cell (Treg) immunotherapy has emerged as a promising and highly effective strategy to combat graft-versus-host disease (GvHD) after allogeneic hematopoietic cell transplantation (allo-HCT).Memnon Lysandrou, Dionysia Kefala, Panayiota Christofi, Panayiota Christofi, Nikolaos Savvopoulos, Penelope Georgia Papayanni, Rodanthy Theodorellou, Eleftheria Sagiadinou, Vassiliki Zacharioudaki, Maria Moukouli, Dimitrios Tsokanas, Georgios Karavalakis, Maria Liga, Konstantinos Stavrinos, Anastasia Papadopoulou, Evangelia Yannaki, Alexandros Spyridonidis +16 moredoaj +1 more sourceComparative Drug Response Profiling in Neuroblastoma Cell Lines and Patient‐Derived Tumor Organoids
Pediatric Blood &Cancer, EarlyView.ABSTRACT
High‐risk neuroblastoma remains a leading cause of pediatric cancer mortality, and improved preclinical models are needed to guide therapeutic developments. We screened seven high‐risk neuroblastoma cell lines and three patient‐derived tumor organoids with 528 compounds alongside bone marrow controls, and compared them with external datasets ...Krzysztof Wierbiłowicz, Se Whee Sammy Park, Aironas Los, Ernest Liu, Nona Struyf, Tom Erkers, Sören Lehmann, Jan J. Molenaar, Jakob Stenman, Olli Kallioniemi, Päivi Östling, Brinton Seashore‐Ludlow, Kasper Karlsson +12 morewiley +1 more sourceRetrospective Analysis of Donor Lymphocyte Infusions in Pediatric Patients With Mixed Chimerism After Hematopoietic Stem Cell Transplantation
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background
Allogeneic hematopoietic stem cell transplantation (alloHSCT) is an essential therapy for several malignant and nonmalignant diseases, but relapse and graft loss remain the principal threats to its success. Routine monitoring of chimerism and minimal residual disease (MRD) enables early detection of imminent recurrence and guides ...Carmen Junk, Sebastian Michaelis, Michaela Döring, Thomas Eichholz, Ursula Holzer, Martin Ebinger, Tim Flaadt, Rupert Handgretinger, Peter Lang, Jan Frederic Weller, Markus Mezger +10 morewiley +1 more sourceSubclinical myocardial changes after hematopoietic stem cell transplantation: limited predictive value of early biomarkers and strain imaging
Cardio-OncologyBackground Cardiotoxicity is a relevant late complication after hematopoietic stem cell transplantation. Early identification of subclinical myocardial injury could allow preventive interventions, yet the optimal diagnostic approach in this setting ...Ana Carolina Oliver, Federico Superchi, Roberto Superchi, Matilde Canabal, Carolina Errecarte, Ricardo Mosquera, Ada Caneiro, Silvia Pierri, Sebastian Galeano, Eloisa Riva, Laura Bello, Regis Gai, Silvana Jubin, Pablo Muxi +13 moredoaj +1 more sourceVenetoclax‐Based Therapy as a Bridge to Hematopoietic Stem Cell Transplantation in Relapsed or Refractory Pediatric Acute Leukemia
Pediatric Blood &Cancer, EarlyView.ABSTRACT
Relapsed and/or refractory (R/R) pediatric acute leukemia carries a dismal prognosis, largely driven by chemoresistance to conventional salvage therapy. The BH3‐mimetic venetoclax, combined with chemotherapy or hypomethylating agents, has demonstrated efficacy in small clinical trials.Katherine S. Colman, Deborah Meyran, Vajiranee Malalasekera, Heather Weerdenburg, Janine Campbell, Rachel Conyers, Stacie Wang, Hannah Walker, Seong Lin Khaw, Diane Hanna +9 morewiley +1 more sourceIslet cell transplantation [PDF]
Postgraduate Medical Journal, 2007 Abstract People with type 1 diabetes have normal exocrine pancreatic function, making islet cell rather than whole organ transplantation an attractive option. Achieving insulin independence in type 1 diabetes was the perceived goal of islet cell transplantation.Srinivasan, P, Huang, G C, Amiel, S A, Heaton, N D +3 moreopenaire +3 more sourcesBone Mineral Density After Contemporary Treatment for Acute Lymphoblastic Leukaemia: A Matched Cross‐Sectional Study
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background
Reduced bone mineral density (BMD) has been reported in survivors of childhood and young adult acute lymphoblastic leukaemia (ALL); however, data from cohorts treated with contemporary protocols and including matched controls remain limited.Karen Schow Jensen, Mette Tiedemann Skipper, Niels Holtum Birkebæk, Kjeld Schmiegelow, Thomas Leth Frandsen, Bente Langdahl, Rikke Beck Jensen, Asger Roer Pedersen, Christian Mølgaard, Liv Andrés‐Jensen, Birgitte Klug Albertsen +10 morewiley +1 more sourceHematopoietic cell transplantation and cellular therapies in Switzerland. Evolution over 25 years. A report from the stem cell transplantation and cellular therapies working groups of the SBST 1997-2021 [PDF]
The Swiss Blood Stem Cell Transplantation and Cellular Therapy Group (SBST) leads a mandatory national registry for all hematopoietic stem cell transplants (HCT) and cellular therapies.Güngör, Tayfun; https://orcid.org/, Renner, Christoph, Ansari, Marc; https://orcid.org/, Schanz, Urs, Chalandon, Yves; https://orcid.org/, Diepold, Miriam, Nair, Gayathri, Baldomero, Helen; https://orcid.org/, Wannesson, Luciano, Pabst, Thomas; https://orcid.org/, Halter, Jörg P, Passweg, Jakob R; https://orcid.org/, Gerull, Sabine; https://orcid.org/, Diesch-Furlanetto, Tamara, Schneidawind, Dominik, Swiss Blood Stem Cell Transplantation Group (SBST), Stussi, Georg; https://orcid.org/, Duchosal, Michel A, Hitz, Felicitas; https://orcid.org/, Holbro, Andreas, Masouridi-Levrat, Stavroula, Heim, Dominik, Arber, Caroline, Daskalakis, Michael; https://orcid.org/, Novak, Urban, Passweg, J.R., Hitz, F., Chalandon, Yves, Duchosal, M.A., Schneidawind, D., Ansari, M., Novak, U., Renner, C., Hitz, Felicitas, Passweg, Jakob R, Diepold, M., Schanz, U., Gerull, S., Arber, C., Daskalakis, M., Pabst, Thomas, Nair, G., Chalandon, Y., Diesch-Furlanetto, T., Masouridi Levrat, Stavroula, Daskalakis, Michael, Ansari Djaberi, Marc Georges, Heim, D., Halter, J.P., Baldomero, H., Masouridi-Levrat, S., Stussi, Georg, Ansari, Marc, Güngör, T., Wannesson, L., Pabst, T., Stussi, G., Gerull, Sabine, Güngör, Tayfun, Holbro, A., Baldomero, Helen +60 morecore +1 more source